Cargando…
Deliberative Processes by Health Technology Assessment Agencies: A Reflection on Legitimacy, Values and Patient and Public Involvement Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
Legitimacy of deliberation processes leading to recommendations for public financing or clinical practice depends on the data considered, stakeholders involved and the process by which both of these are selected and organised. Oortwijn et al provides an interesting exploration of processes currently...
Autores principales: | Goetghebeur, Mireille, Cellier, Marjo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kerman University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167272/ https://www.ncbi.nlm.nih.gov/pubmed/32610794 http://dx.doi.org/10.34172/ijhpm.2020.46 |
Ejemplares similares
-
HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
por: Schlander, Michael
Publicado: (2020) -
Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe
por: Oortwijn, Wija, et al.
Publicado: (2019) -
Use of Evidence-Informed Deliberative Processes – Learning by Doing: Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
por: Culyer, Anthony J.
Publicado: (2019) -
Evidence-Informed Deliberative Processes for HTA Around the Globe: Exploring the Next Frontiers of HTA and Best Practices Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
por: Gopinathan, Unni, et al.
Publicado: (2020) -
The Place and Importance of Patients in Deliberative Processes
por: Cellier, Marjo S.
Publicado: (2021)